Improving Access to Essential Medicines and Basic Technologies for Non-communicable Diseases


Access to medicines and technologies for non-communicable diseases is poor in low and middle-income countries. Building on the Swiss comparative advantage (broader access engagement as a country with a big pharma sector), the program addresses all components of the comprehensive framework for access to drugs, ranging from research and innovation to dispensing and use. It will also set up a dedicated global collaborative network for advocacy, information and innovation.

Country/region Topic Period Budget
Global
Health
Primary health care
Health systems strengthening
01.11.2019 - 31.12.2031
CHF  18’000’000
Directorate/federal office responsible SDC
Credit area Development cooperation
Project partners Contract partner
Swiss Academic and Research Institution
  • Other Swiss academic and research institutions


Budget Current phase Swiss budget CHF    18’000’000 Swiss disbursement to date CHF    0
Project phases Phase 99 01.11.2019 - 31.12.2031   (Current phase)